These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26620227)

  • 1. Differential susceptibility of transgenic mice expressing human surfactant protein B genetic variants to Pseudomonas aeruginosa induced pneumonia.
    Ge L; Liu X; Chen R; Xu Y; Zuo YY; Cooney RN; Wang G
    Biochem Biophys Res Commun; 2016 Jan; 469(2):171-5. PubMed ID: 26620227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory Roles of Human Surfactant Protein B Variants on Genetic Susceptibility to Pseudomonas Aeruginosa Pneumonia-Induced Sepsis.
    Yang F; Zhang J; Yang Y; Ruan F; Chen X; Guo J; Abdel-Razek O; Zuo YY; Wang G
    Shock; 2020 Oct; 54(4):507-519. PubMed ID: 31851120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DIFFERENTIAL SUSCEPTIBILITY OF HUMAN SP-B GENETIC VARIANTS ON LUNG INJURY CAUSED BY BACTERIAL PNEUMONIA AND THE EFFECT OF A CHEMICALLY MODIFIED CURCUMIN.
    Xu Y; Ge L; Abdel-Razek O; Jain S; Liu Z; Hong Y; Nieman G; Johnson F; Golub LM; Cooney RN; Wang G
    Shock; 2016 Apr; 45(4):375-84. PubMed ID: 26863117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: implications for disease.
    Wang G; Christensen ND; Wigdahl B; Guttentag SH; Floros J
    Biochem J; 2003 Jan; 369(Pt 1):179-84. PubMed ID: 12356334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo.
    Chroneos ZC; Wert SE; Livingston JL; Hassett DJ; Whitsett JA
    J Immunol; 2000 Oct; 165(7):3941-50. PubMed ID: 11034402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas aeruginosa and Surfactant-associated Proteins A and D].
    Faure K; Leberre R; Guery B
    Med Mal Infect; 2006 Feb; 36(2):63-71. PubMed ID: 16406431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection.
    LeVine AM; Kurak KE; Bruno MD; Stark JM; Whitsett JA; Korfhagen TR
    Am J Respir Cell Mol Biol; 1998 Oct; 19(4):700-8. PubMed ID: 9761768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.
    Giannoni E; Sawa T; Allen L; Wiener-Kronish J; Hawgood S
    Am J Respir Cell Mol Biol; 2006 Jun; 34(6):704-10. PubMed ID: 16456184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune collectin surfactant protein D simultaneously binds both neutrophil extracellular traps and carbohydrate ligands and promotes bacterial trapping.
    Douda DN; Jackson R; Grasemann H; Palaniyar N
    J Immunol; 2011 Aug; 187(4):1856-65. PubMed ID: 21724991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A.
    Tan RM; Kuang Z; Hao Y; Lee F; Lee T; Lee RJ; Lau GW
    Infect Immun; 2015 Apr; 83(4):1339-46. PubMed ID: 25605768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia.
    Birkun AA; Kubyshkin AV; Novikov NY; Krivorutchenko YL; Fedosov MI; Postnikova ON; Snitser AA
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):299-307. PubMed ID: 25517041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia.
    Vanderzwan J; McCaig L; Mehta S; Joseph M; Whitsett J; McCormack DG; Lewis JF
    Eur Respir J; 1998 Dec; 12(6):1388-96. PubMed ID: 9877497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cell activity is partly inhibited in a mouse model of chronic Pseudomonas aeruginosa lung infection.
    Ding FM; Zhu SL; Shen C; Ji XL; Zhou X
    Exp Lung Res; 2015 Feb; 41(1):44-55. PubMed ID: 25398094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory reaction and alterations of pulmonary surfactant in Pseudomonas Aeruginosa pneumonia in immunocompromised rats.
    Qu J; Li Z; He L; Sun B; Chen X
    Chin Med J (Engl); 2002 Jul; 115(7):1099-100. PubMed ID: 12173603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of epithelial sodium channel (ENaC) expression in mouse lung infected with Pseudomonas aeruginosa.
    Dagenais A; Gosselin D; Guilbault C; Radzioch D; Berthiaume Y
    Respir Res; 2005 Jan; 6(1):2. PubMed ID: 15636635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased surfactant protein D fails to improve bacterial clearance and inflammation in serpinB1-/- mice.
    Stolley JM; Gong D; Farley K; Zhao P; Cooley J; Crouch EC; Benarafa C; Remold-O'Donnell E
    Am J Respir Cell Mol Biol; 2012 Dec; 47(6):792-9. PubMed ID: 23024061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific N-glycosylation delays human surfactant protein B secretion in vitro and associates with decreased protein levels in vivo.
    Taponen S; Huusko JM; Petäjä-Repo UE; Paananen R; Guttentag SH; Hallman M; Haataja R
    Pediatr Res; 2013 Dec; 74(6):646-51. PubMed ID: 24002332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.
    Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K
    Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein B inhibits endotoxin-induced lung inflammation.
    Epaud R; Ikegami M; Whitsett JA; Jobe AH; Weaver TE; Akinbi HT
    Am J Respir Cell Mol Biol; 2003 Mar; 28(3):373-8. PubMed ID: 12594064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Anti-Infective Pulmonary Proteins: In Vivo Cooperative Action of Surfactant Protein SP-A and the Lung Antimicrobial Peptide SP-BN.
    Coya JM; Akinbi HT; Sáenz A; Yang L; Weaver TE; Casals C
    J Immunol; 2015 Aug; 195(4):1628-36. PubMed ID: 26163587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.